Recent Updates
Recently added Catalysts
MGNX Neutral Sentiment Score: 55/100

MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call

Tuesday, February 27, 2024 2 min read
Key Takeaway: MacroGenics, Inc. has announced the date for its fourth quarter 2023 financial results, which will be released on March 7, 2024. Following the results, the company will host a conference call at 4:30 pm ET to discuss its financial performance and recent corporate developments. Investors can register to participate via telephone or listen to a webcast on the company's Investor Relations website. A recorded replay will be available shortly after the call for those unable to attend.

Market Sentiment Analysis

POSITIVE FACTORS

  • MacroGenics is preparing to release its financial results, indicating ongoing operations.
  • The company has made progress in developing innovative therapeutics.
  • There is an upcoming conference call to share insights on financial results.

Full Press Release Details

ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter of 2023 after the market closes on Thursday, March 7, 2024. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, March 7, 2024, at 4:30 pm ET.
Conference Call Information
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. The listen-only webcast of the conference call can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at http://ir.macrogenics.com/events.cfm. A recorded replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Tags

Antibody-drug Conjugate

Frequently Asked Questions

When will MacroGenics announce its Q4 2023 financial results?

MacroGenics will release its Q4 2023 financial results on March 7, 2024.

How can I join the MacroGenics conference call?

You can register in advance via a provided link to join the conference call.

Where can I find the recorded replay of the call?

The recorded replay will be available on MacroGenics' website for 30 days.

What is the focus of MacroGenics, Inc.?

MacroGenics focuses on developing antibody-based therapeutics for cancer treatment.

What technology does MacroGenics use for its product candidates?

MacroGenics utilizes proprietary next-generation antibody-based technology platforms.

Tags: MGNX Viatris Investor Conferences Healthcare MacroGenics financial results conference call biopharmaceuticals
Last updated: Feb 27, 2024